Dysgammaglobulinemia

Dysgammaglobulinemia is a rare disease characterized by impaired production of gamma globulins in the blood. These antibodies are part of the immune system and protect the body from infections. However, in dysgammaglobulinemia, the production of gamma globulins is impaired, which can lead to various complications such as frequent infections, autoimmune diseases and other health problems.

Dysgammaglobulinemia can be diagnosed using various laboratory tests, such as antibody blood tests and immunological tests. Treatment for dysgammaglobulinemia may include taking immunoglobulin drugs, which help improve the production of gamma globulins. Other treatments, such as a bone marrow transplant or stem cell therapy, may also be used.

It is important to note that dysgammaglobulinemia is a rare disease and its diagnosis can be difficult. Therefore, it is important to consult a doctor if you suspect this disease and undergo all the necessary tests to confirm the diagnosis.

Dysgammaglobulinemia DHT is an inherited autoimmune disorder in which the patient's cells cannot cope with the body's defense against infections. Despite this term, “dysgamma globulinemia” implies a hereditary pathology caused by disorders of the T-lymphocyte component of immunity.

dsm I The subgroup of the disease includes a non-viral form in which a disorder is possible against the background of the sentinel function of the immune system, which is called “acquired immunodeficiency syndrome”. The immune system works normally, but atypia syndrome causes disorders associated with nonspecific manifestations of pathology. dsm II Wiskott Aldrich syndrome involves mutations in the WASP, STK11, LIMCH8 genes, which caused a hereditary disruption of the connection between the T and B systems. This form is characterized by acquired underdeveloped and abnormal antibodies, in addition, immune cells, as a rule. Independent and not involved